Genetico is a health technology company developing digital solutions for the rare and genetic disease ecosystem
We work with clinicians, hospitals, laboratories, researchers and public-health programmes to connect the information that rare disease care depends on. Our platform, IndiGeneUs.AI, is how that work is delivered.
Clinicians, engineers and data scientists
A health technology company working on rare and genetic disorders.
IndiGeneUs.AI
AI-enabled platform for clinical data, decision support, longitudinal records and analytics.
AIIMS New Delhi, CDFD Hyderabad and 15 centres
Rare disease centres engaged under the PraGed Mission.
Rare diseases are complex. The systems supporting them shouldn’t be.
Information about a single patient is spread across clinicians, hospitals, laboratories, research programmes and public-health systems — in different formats, and rarely connected. That fragmentation slows diagnosis, weakens follow-up and leaves research and planning without reliable data.
Diagnosis is slow
Patients see several specialists before a genetic diagnosis, and each visit starts from a new file.
Records don't travel
Notes, lab reports and images sit on paper and in separate systems, so history is rebuilt at every centre.
Nothing adds up
Without structured data there are no cohorts for research and no registry for planning.
Genetico was created to connect that information — so that diagnosis, follow-up, research and planning can build on the same record.
Connecting information. Enabling better decisions.
Genetico works across five connected areas of the rare disease ecosystem. Each draws on the same structured information.
Clinical care
Structured consultations and decision support in genetics and rare disease clinics.
Longitudinal care
One record per patient across visits, laboratories and centres.
Research and life sciences
Research-ready data and cohorts drawn from routine care.
Registries and programmes
Registry entries and programme reporting from the clinical workflow.
Public health
Population-level insight for programme planning.
Information recorded once in clinical care serves every area that follows — nothing is entered twice.
Genetico is the company. IndiGeneUs.AI is the platform.
IndiGeneUs.AI is Genetico's AI-enabled platform for connecting clinical data, decision support, longitudinal information and analytics.
The companyWorks with hospitals, laboratories, researchers and government programmes to connect the rare disease ecosystem.
Partnerships, clinical deployment, research collaborations and programme design.
IndiGeneUs.AIThe software that makes this operational — used during the consultation, alongside existing hospital systems.
See the platformPhenotype, history and documents recorded as structured fields at the point of care.
Ranked differentials with the evidence behind each one, reviewed by the treating team.
One longitudinal record per patient across visits, departments and centres.
Cohorts, registries and dashboards from the data the clinic already produced.
Why the opportunity exists now
Several changes have arrived together. Between them, connected rare disease infrastructure has become practical in India.
What we are working towards
To equip clinicians, institutions and researchers with AI-enabled workflows and structured data that improve care and accelerate discovery.
To build the digital backbone for the rare disease ecosystem — connecting patient care, research and public health at scale.
From digital solutions to connected infrastructure
Where we are goingCentres of Excellence
Structured consultations and decision support in genetics clinics across the network.
Connected research
Multi-site cohorts and natural history studies drawn from the same routine-care record.
National infrastructure
A registry that fills from routine care and informs rare disease programme planning.
A direction of travel, not dated commitments.
The people behind Genetico
Clinicians, engineers, data scientists and advisors with experience across genetics, health systems and technology.
Clinician-led, not clinician-facing
Every workflow is designed with the doctors who will use it. If it adds a minute to a consultation, it does not ship.
Structure before intelligence
AI is only as good as the record beneath it. We fix capture first — decision support, cohorts and registries follow from the same data.
Built with institutions, not around them
We work inside existing hospital systems, national programmes and standards rather than asking anyone to replace what already works.
Rewards & Recognition
Recognized and supported by leading government bodies, incubators, and innovation programs across India.
- 2019
Biotech Ignition Grant — BIRACDepartment of Biotechnology, Govt. of India - 2020
Seed Investment — IIT MandiNIDHI SSS - 2022
India-Sweden Healthcare Innovation ChallengeWinner - 2024
Startup Maharathi AwardStartup Mahakumbh — Hon'ble Minister Piyush Goyal - 2024
HDFC Bank Parivartan CSR GrantCorporate Social Responsibility - 2025
Scale-up Grant — MeitYMinistry of Electronics & Information Technology
Trusted Across the Rare Disease Ecosystem
We collaborate with leading institutions, research organizations, and public health programs building the future of rare disease care in India and beyond.
Built for trust. Designed for healthcare.
Advancing the Rare Disease Ecosystem Starts with Collaboration
We work alongside clinicians, institutions, researchers, and public health programs to build intelligent infrastructure that transforms fragmented data into better decisions and better outcomes.